Lehman & Derafelo Financial Resources’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-5,060
| Closed | -$559K | – | 179 |
|
2022
Q3 | $559K | Sell |
5,060
-75
| -1% | -$8.29K | 0.18% | 52 |
|
2022
Q2 | $385K | Buy |
+5,135
| New | +$385K | 0.12% | 68 |
|
2021
Q3 | – | Sell |
-12,517
| Closed | -$973K | – | 221 |
|
2021
Q2 | $973K | Buy |
12,517
+1,000
| +9% | +$77.7K | 0.27% | 51 |
|
2021
Q1 | $858K | Buy |
11,517
+1,575
| +16% | +$117K | 0.24% | 51 |
|
2020
Q4 | $1.7M | Sell |
9,942
-239
| -2% | -$40.7K | 0.51% | 35 |
|
2020
Q3 | $1.43M | Sell |
10,181
-261
| -2% | -$36.7K | 0.46% | 31 |
|
2020
Q2 | $1.67M | Sell |
10,442
-1,000
| -9% | -$160K | 0.58% | 31 |
|
2020
Q1 | $1.12M | Sell |
11,442
-3,300
| -22% | -$323K | 0.47% | 37 |
|
2019
Q4 | $1.9M | Hold |
14,742
| – | – | 0.68% | 31 |
|
2019
Q3 | $1.11M | Buy |
14,742
+7,300
| +98% | +$550K | 0.42% | 41 |
|
2019
Q2 | $1.12M | Hold |
7,442
| – | – | 0.46% | 39 |
|
2019
Q1 | $887K | Hold |
7,442
| – | – | 0.38% | 42 |
|
2018
Q4 | $812K | Buy |
+7,442
| New | +$812K | 0.4% | 38 |
|